Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03477175
Title Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Patients in Eisai Sponsored Lenvatinib Trials
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eisai Inc.
Age Groups: senior | adult
Covered Countries USA | ITA | DEU | BEL

No variant requirements are available.